Ikarian Capital LLC 13D and 13G filings for Millendo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | Millendo Therapeutics, Inc. MLND | Ikarian Capital LLC | 58,803 0.900% | -31,065 (-34.57%) | Filing |
| 2021-04-07 5:25 pm Purchase | 2021-03-18 | 13G | Millendo Therapeutics, Inc. MLND | Ikarian Capital LLC | 89,868 7.100% | 89,868 (New Position) | Filing |